SHPH SHUTTLE PHARMACEUTICALS HOLDINGS INC Capital Structure Changes 8-K Filing 2025 - Loan Agreement On February 28, 2025, Shuttle Pharmaceuticals entered into a $2 million revolving loan agreement and appointed three new directors after four existing directors resigned. The loan has an 18% interest rate and is intended for general corporate purposes, including a potential public equity offering of up to $6 million.Get access to all SEC 8-K filings of the SHUTTLE PHARMACEUTICALS HOLDINGS INC